HBsAg level and clinical course in patients with chronic hepatitis B treated with nucleoside analogue: five years of follow-up data

BACKGROUND/AIMS: Quantification of the hepatitis B surface antigen (HBsAg) is increasingly used to determine the treatment response in patients with chronic hepatitis B (CHB). However, there are limited data about the clinical implications of Quantification of HBsAg long-term nucleoside analogue tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jeong Han, Choi, Yun Jung, Moon, Hee Won, Ko, Soon Young, Choe, Won Hyeok, Kwon, So Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894441/
https://www.ncbi.nlm.nih.gov/pubmed/24459646
http://dx.doi.org/10.3350/cmh.2013.19.4.409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894441/
https://www.ncbi.nlm.nih.gov/pubmed/24459646
http://dx.doi.org/10.3350/cmh.2013.19.4.409

Ejemplares similares